Ian is Managing Partner of Sands Capital Ventures and joined in January 2016. He is a serial entrepreneur and has 20 years of experience starting and investing in life sciences technology businesses as an angel, venture and private equity investor. Ian has served in many roles as a founder, CEO, CFO, COO, chairman, director, and advisor to a number of privately-held Life Science product and service businesses.

 

He has focused on the cell signaling, drug screening, genomics and sequencing, and cell structure and modification segments, at all stages of business development from initiation through profitability to trade sale. Prior to joining Sands Capital, Ian was the Chairman and CEO of Enzymatics Inc., founder and CEO of Stemgent, Inc., a stem and iPS cell life sciences tool, and President of Upstate Inc., a leading provider of cell signaling research products and services. Ian was also a founding investor in Firefly Bioworks and Genometry, both SCV investments.

 

Ian has a degree in Chemical Engineering from University of Surrey and has a MBA from the Darden School at the University of Virginia.